ReSET Aim 1a: Restarting Safe Education and Testing for Children With Medical Complexity - Feasibility of In-home Cohort COVID-19 Testing Strategies, and Associations With CMC Parent Perceptions About In-person School Attendance
Study Details
Study Description
Brief Summary
The purpose of this research study is to learn about the factors parents consider when deciding whether their child will go to school in-person or attend from home. Investigators are also interested in learning whether access to in-home COVID testing is of value to parents and also whether it affects decision-making about returning to school.
This study is being done at UW-Madison in partnership between the Department of Pediatrics and the Department of Industrial and Systems Engineering. A total of 50 caregivers (plus their children with medical complexity) will participate in this study. Additionally, 20 caregivers involved in the study may also be invited to participate in a one-hour, virtual visit in which the caregiver demonstrates and discusses how they perform in-home COVID testing with their child.
The results of the study may help researchers advance their understanding of in-home testing strategies for children with medical complexity.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Caregiver of Children with medical complexity (CMC)
|
Diagnostic Test: BinaxNOW Rapid Antigen System
BinaxNOW Rapid Antigen System (Abbott) is a point-of-care, lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct anterior nasal (nares) swabs. Internal controls are built into the testing system and results are available in 15 minutes.
The use of the BinaxNOW system is authorized under the Food and Drug Administration's Emergency Use Authorization. The test is allowed for over-the-counter, non-prescription use with or without symptoms. The test may be used with children two years and older with the help of sample collection by an adult, and the test may be self-administered by anyone aged 15 years or more.
|
Outcome Measures
Primary Outcome Measures
- Change in Protocol uptake: Number of Participants Consented Compared to Number of participants approached [Study duration (up to 21 months)]
Feasibility of home based COVID-19 testing will be evaluated by protocol uptake. Data will be retrieved from the study log.
- Change in Mean number of weekly in home COVID-19 tests [Every week up to 21 months]
Feasibility of home based COVID-19 testing will be evaluated by mean number of weekly in home COVID-19 tests run by parents/caregivers. Data will be collected by survey.
- Change in COVID test rate at home: Number of total tests completed as compared to number of tests expected [Study duration (up to 21 months)]
Data will be collected by survey.
- Change in Symptomatic test rate: number of symptomatic tests completed compared to total number of participants enrolled [Study duration (up to 21 months)]
Data will be collected from parents via survey.
- Change in Positive rate: Number of positive COVID-19 tests compared to total number of tests performed [Study duration (up to 21 months)]
Data will be collected from parents via survey.
- Change in False-positive rate: number of negative confirmatory Polymerase chain reaction (PCR) as compared to total PCR run for COVID-19 testing [Study duration (up to 21 months)]
Data will be collected from parents via survey.
- Surveillance opt in: number of participants opting into surveillance compared to total number of enrolled participants [At month 3]
Data will be collected from parents via survey.
- Change in susceptibility: Number of fully vaccinated people who interact with participant's child at school [baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month]
- Change in susceptibility: Survey items answered dichotomously (agree or disagree) [baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month]
Following questions from the Participant's perceived susceptibility survey will be answered dichotomously (agree or disagree) and presented qualitatively. How comfortable are you with...the ability of your child's school to take all precautions to stop the spread of COVID-19? In your opinion, how likely is your child to get sick with COVID-19 by attending school in-person?
- Change in percentage of participants who chose each option in response to the perceived severity survey question [baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month]
Parent survey perceived severity construct variables will be: "If my child was sick with COVID-19, their health would be severely affected." "If my child was sick with COVID-19, they would have grave health consequences." "If my child was sick with COVID-19, their health would be permanently reduced."
- Change in motivation to attend school (quite a bit / a great deal vs not) [baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month]
Participants will answer the following survey question in quite a bit / a great deal vs not: "Based on the situation right now, how much do you want your child to attend school in-person at least some of the time?"
- Change in perceived benefits to attend school [baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month]
Parent survey perceived benefits construct survey will be having 6 questions ranging from benefits to child's overall health, therapy needs, impact on family. Survey will be analyzed qualitatively.
- Change in barriers to school attendance: Survey answered dichotomously very/extremely [comfortable] vs not. [baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month]
Survey will have following questions which will be answered dichotomously very/extremely [comfortable] vs not. It How comfortable are you with... the number of people around your child at school? how close people have to be to your child at school? the amount personal protective equipment (PPE), such as masks and gloves, available at school? the amount of COVID-19 testing among school staff and classmates? how closely parents of classmates follow recommendations to keep your child safe? How difficult is it to transport your child to or from school as a result of COVID-19? In your child's school, do they have access to necessary facilities to wash? While in school, is your child required to be in close contact (i.e., within 6 ft) with others? 'Others' includes teachers, aides, nurses, and classmates. While in school, is your child able to wear a mask?
- Change in Cues: Has a teacher or staff member encouraged child to attend school in-person? (Y/N) [baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month]
Participants will answer the following survey question in Yes/No: "Teachers/staff have asked for my child to attend school."- Y/N
- Change in option and practice: Currently, if participant wanted, could the child attend school in-person, either full-time or as part of a hybrid or part-time schedule? Y/N [baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month]
Participant will be asked the attendance question in survey. It will be answered in Yes/No
- Change in option and practice: Currently, is child attending school in-person, either full-time or as part of a hybrid or part-time schedule? Y/N [baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month]
Participant will be asked the attendance question in survey. It will be answered in Yes/No
Eligibility Criteria
Criteria
Inclusion Criteria:
In order to be eligible to participate in this study, the caregiver/child must meet the following criteria:
-
The caregiver is willing to comply with all study procedures and expects to be available for the duration of the study.
-
The caregiver is at least 18 years of age.
-
The caregiver is proficient in English.
-
The caregiver is self-identified as the primary caregiver (parent, foster parent, legal guardian) of a CMC who is aged 5-16 years at the start of the study and who is enrolled in the Pediatric Complex Care Program (PCCP) at the University of WI-Madison.
-
The caregiver is currently providing care on an ongoing basis to their CMC. The child may not be housed in a skilled nursing facility, an acute care or transitional facility, a rehabilitative hospital, a medical group home or in a foster home (unless the primary caregiver for the study is the foster parent).
-
The caregiver has access to a web-enabled device (phone, tablet, or computer).
-
Caregiver and child are residents of Wisconsin.
-
The child attended in-person school pre-pandemic. (Child can currently be attending school in-person, remotely or a hybrid combination).
-
The caregiver provides a written informed consent form.
Exclusion Criteria:
-
Failure to meet all inclusion criteria.
-
The child is hospitalized at the time of enrollment (visit may be rescheduled)
-
Children not currently enrolled in public or private school and whose caregiver has no plan to enroll them in the Fall of 2021 (e.g., children currently homeschooling with plans to homeschool in the Fall of 2021 are ineligible).
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University of Wisconsin School of Medicine and Public Health | Madison | Wisconsin | United States | 53792-4108 |
Sponsors and Collaborators
- University of Wisconsin, Madison
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Investigators
- Principal Investigator: Ryan Coller, MD, MPH, University of Wisconsin, Madison
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2021-0462
- 1OT2HD107558-01
- A536771
- SMPH/PEDIATRICS
- Protocol Version 04/12/21
- 2022-0594